Tech Data Corp. (NASDAQ:TECD) shares moved down -10.09% in last trading session and ended the day at $68.09. TECD Gross Margin is 5.00% and its has a return on assets of 4.00%. Tech Data Corp. (NASDAQ:TECD) quarterly performance is 9.08%.
Tech Data Corp. (NASDAQ:TECD) reported Gross profit was $314.8 million, or 4.90 percent of net sales, compared to $335.0 million, or 4.95 percent of net sales in the prior-year quarter. On a constant currency basis, gross profit improved approximately $9 million, or 3 percent year-over-year.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ended the last trading day at $57.46. Company weekly volatility is calculated as 6.10% and price to cash ratio as 4.84. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) showed a weekly performance of 16.15%.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), announced it participated in the Jefferies Autumn 2015 Global Healthcare Conference in London on Thursday, Nov. 19, 2015. Sharon Mates, Ph.D., Chief Executive Officer and Chairman, presented at 10:40 a.m. GMT.
On 24 November, Raytheon Company (NYSE:RTN) shares moved down -0.32% and was closed at $126.36. RTN EPS growth in last 5 year was 7.30%. Raytheon Company (NYSE:RTN) year to date (YTD) performance is 19.75%.
Raytheon Company (NYSE:RTN) announced that Raytheon Chairman and CEO Thomas A. Kennedy and Raytheon Vice President and Chief Financial Officer Anthony F. O’Brien will speak at the Credit Suisse 3rd Annual Industrials Conference on Tuesday, Dec. 1, 2015.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares remains unchanged in last trading session and ended the day at $1.22. CLRB has a return on assets of -99.50%. Cellectar Biosciences, Inc. (NASDAQ:CLRB) quarterly performance is -61.02%.
Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, announces that its chief scientific officer and company founder, Jamey Weichert, Ph.D., received the Harry Fisher award for excellence in contrast media research during the 2015 Contrast Media Research Congress (CMR) held in Berlin, Germany November 8-11, 2015.
Chimerix, Inc. (NASDAQ:CMRX) caters to the Healthcare space. Its weekly performance is 1.88%. On the last day of trading company shares ended up at $40.18.
Chimerix (NASDAQ:CMRX), announced that M. Michelle Berrey, M.D., M.P.H., President and Chief Executive Officer of Chimerix, will present at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2015 at 11:30 a.m. ET at the Lotte New York Palace Hotel in New York City.
Leave a Reply